FDA advisory panel recommends revoking sale of preterm birth drug
FDA advisory panel recommends revoking sale of preterm birth drug
Source: kmmo.com
Stay updated with breaking news from Peter Stein. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FDA advisory panel recommends revoking sale of preterm birth drug
WASHINGTON (dpa-AFX) - A US Food and Drug Administration or FDA advisory committee voted on Wednesday that a drug approved more than ten years ago to bring down the risk of pre-term birth should
Makena is ineffective, argued FDA panel
An FDA panel recommends that a drug approved to prevent premature birth be removed from the market because it doesn't work and carries risks.